Literature DB >> 21261127

Medicare program; end-stage renal disease quality incentive program. Final rule.

.   

Abstract

This final rule will implement a quality incentive program (QIP) for Medicare outpatient end-stage renal disease (ESRD) dialysis providers and facilities with payment consequences beginning January 1, 2012, in accordance with section 1881(h) of the Act (added on July 15, 2008 by section 153(c) of the Medicare Improvements for Patients and Providers Act (MIPPA)). Under the ESRD QIP, ESRD payments made to dialysis providers and facilities under section 1881(b)(14) of the Social Security Act will be reduced by up to two percent if the providers/facilities fail to meet or exceed a total performance score with respect to performance standards established with respect to certain specified measures.

Entities:  

Mesh:

Year:  2011        PMID: 21261127

Source DB:  PubMed          Journal:  Fed Regist        ISSN: 0097-6326


  16 in total

1.  Effect of Medicare dialysis payment reform on use of erythropoiesis stimulating agents.

Authors:  Shailender Swaminathan; Vincent Mor; Rajnish Mehrotra; Amal N Trivedi
Journal:  Health Serv Res       Date:  2014-10-30       Impact factor: 3.402

2.  Characteristics and performance of minority-serving dialysis facilities.

Authors:  Yoshio N Hall; Ping Xu; Glenn M Chertow; Jonathan Himmelfarb
Journal:  Health Serv Res       Date:  2013-12-20       Impact factor: 3.402

3.  Referral for Kidney Transplantation and Indicators of Quality of Dialysis Care: A Cross-sectional Study.

Authors:  Laura C Plantinga; Stephen O Pastan; Adam S Wilk; Jenna Krisher; Laura Mulloy; Eric M Gibney; Rachel E Patzer
Journal:  Am J Kidney Dis       Date:  2016-11-20       Impact factor: 8.860

Review 4.  The ESRD Quality Incentive Program-Can We Bridge the Chasm?

Authors:  Daniel Weiner; Suzanne Watnick
Journal:  J Am Soc Nephrol       Date:  2017-03-15       Impact factor: 10.121

5.  Proximity Does Not Equal Access: Racial Disparities in Access to High Quality Dialysis Facilities.

Authors:  Milda R Saunders; Haena Lee; Chieko Maene; Todd Schuble; Kathleen A Cagney
Journal:  J Racial Ethn Health Disparities       Date:  2014-12-01

6.  Medicare's payment strategy for end-stage renal disease now embraces bundled payment and pay-for-performance to cut costs.

Authors:  Shailender Swaminathan; Vincent Mor; Rajnish Mehrotra; Amal Trivedi
Journal:  Health Aff (Millwood)       Date:  2012-09       Impact factor: 6.301

7.  Patient-Reported Experiences of Dialysis Care Within a National Pay-for-Performance System.

Authors:  Brian M Brady; Bo Zhao; Jingbo Niu; Wolfgang C Winkelmayer; Arnold Milstein; Glenn M Chertow; Kevin F Erickson
Journal:  JAMA Intern Med       Date:  2018-10-01       Impact factor: 21.873

8.  Patient Satisfaction Is Associated With Dialysis Facility Quality and Star Ratings.

Authors:  Abhijit V Kshirsagar; Amir Alishahi Tabriz; Heejung Bang; Shoou-Yih D Lee
Journal:  Am J Med Qual       Date:  2018-09-18       Impact factor: 1.852

9.  Exploring Care Attributes of Nephrologists Ranking Favorably on Measures of Value.

Authors:  Brian M Brady; Meera V Ragavan; Melora Simon; Glenn M Chertow; Arnold Milstein
Journal:  J Am Soc Nephrol       Date:  2019-11-14       Impact factor: 10.121

10.  Association of dialysis facility-level hemoglobin measurement and erythropoiesis-stimulating agent dose adjustment frequencies with dialysis facility-level hemoglobin variation: a retrospective analysis.

Authors:  Irfan Khan; Mahesh Krishnan; Anupam Kothawala; Akhtar Ashfaq
Journal:  BMC Nephrol       Date:  2011-05-20       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.